Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NASDAQ Listing Requirements
MNGA just closed over $1.00 for the 10th straight trading day. MagneGas has met the NASDAQ listing requirements and is now in compliance with the NASDAQ guidelines.
The following message details yesterday's MangeGas presentation. It was posted to the MagneGas message board on YahooFinance. The account name that posted it is "unclegianni".
The demo day was very informative and quite fun...it is always good to put a face to a name and the folks I met yesterday at the event were genuine and provided very good information.
There were questions posted that I would like to answer, so here we go:
1: The gas that is produced from "sewage" based feedstock is not as potent as the gas produced from "oil" based feedstock. It will not have the same characteristics as the gas that is being positioned for the co-combustion plans.
2: MNGA has experience processing sewage in Italy, they have been doing it there for a long time. The sterilization process is faster and eliminates all pathogens - so the water and other by-products (clean "sludge") can be used for irrigation, put back into the environment cleanly and be used in the other application like fertilizer.
3: The European, and other distributors, are independent companies, MNGA does not maintain any ownership in them.
4: A lot of time was spent on the slow adoption of MNGA versus Acetylene. The long and short of it are that they are breaking into a market that has not changed in 40 plus years and that quite simply takes time, consistency and effort. There are lots of road blocks but the team at MNGA has opted to take a top down approach and work with the trade unions and Fire Departments to educate them on the benefits and have them endorse and use the product to that others will see instant validation. Think of the process that someone would have to go thru in NYC in order to use a new gas, it does not happen unless the Fire Department is on board, plain and simple. Start at the top and will flow down. There was a continuous theme about the level of success in the demonstrations and presentations to everyone from pipe cutters and emergency service all the way up to former GE scientists that feel once the market accepts the facts and adopts the change that this valuation could be well into the billions.
5. They company has ZERO debt, they are self funding at this point. Sales are fairly steady and on the rise and they did not express an immediate need to bring in capital.
6. The Co-Combustion process was discussed in detail - what they told us was practically unbelievable. MagneGas will be used in the "cleaning" process at coal plants. It will be introduced to the smoke and particulate matter that comes out of a "smoke stack" and applied to burn the particulate and reduce smoke emissions to "zero". The additional heat that is created can be re-introduced into the steam creation process kind of like a turbo charge or after burn and enhance the overall output for the facility while at the same time practically eliminating emission issues.
7. Syngas VS Magnegas - the process is different in creating the gas and MNGA does it faster and cleaner and the resulting MagneGas burns more the 3X hotter than any of it's possible competitors. Competition is not that deep - acetylene and propane are the majors and there are inherent problems with both from volatility with acetylene and wide burn area with Propane.
8: Flame temp. was discussed and it should be considered a fact that MagneGas burns at temps pushing 12000 to 15000 degress - period end of story. They are working on perfecting a new verison of the gas that will consistently burn at 15000 degrees, it is derived from oil based feedstocks. This was the most impressive part of the day for me. It was a very enlightening discussion.
9: IP and possible Patent Infringement - MNGA is not infringing on anyone else's patents. There process is different than other processes intended for "Liquid Gasification" process, in addition to the desired end result being only Magnegas.
So that answers the questions posted.
The following message details yesterday's MangeGas presentation. It was posted to the MagneGas message board on YahooFinance. The account name that posted it is "unclegianni".
The demo day was very informative and quite fun...it is always good to put a face to a name and the folks I met yesterday at the event were genuine and provided very good information.
There were questions posted that I would like to answer, so here we go:
1: The gas that is produced from "sewage" based feedstock is not as potent as the gas produced from "oil" based feedstock. It will not have the same characteristics as the gas that is being positioned for the co-combustion plans.
2: MNGA has experience processing sewage in Italy, they have been doing it there for a long time. The sterilization process is faster and eliminates all pathogens - so the water and other by-products (clean "sludge") can be used for irrigation, put back into the environment cleanly and be used in the other application like fertilizer.
3: The European, and other distributors, are independent companies, MNGA does not maintain any ownership in them.
4: A lot of time was spent on the slow adoption of MNGA versus Acetylene. The long and short of it are that they are breaking into a market that has not changed in 40 plus years and that quite simply takes time, consistency and effort. There are lots of road blocks but the team at MNGA has opted to take a top down approach and work with the trade unions and Fire Departments to educate them on the benefits and have them endorse and use the product to that others will see instant validation. Think of the process that someone would have to go thru in NYC in order to use a new gas, it does not happen unless the Fire Department is on board, plain and simple. Start at the top and will flow down. There was a continuous theme about the level of success in the demonstrations and presentations to everyone from pipe cutters and emergency service all the way up to former GE scientists that feel once the market accepts the facts and adopts the change that this valuation could be well into the billions.
5. They company has ZERO debt, they are self funding at this point. Sales are fairly steady and on the rise and they did not express an immediate need to bring in capital.
6. The Co-Combustion process was discussed in detail - what they told us was practically unbelievable. MagneGas will be used in the "cleaning" process at coal plants. It will be introduced to the smoke and particulate matter that comes out of a "smoke stack" and applied to burn the particulate and reduce smoke emissions to "zero". The additional heat that is created can be re-introduced into the steam creation process kind of like a turbo charge or after burn and enhance the overall output for the facility while at the same time practically eliminating emission issues.
7. Syngas VS Magnegas - the process is different in creating the gas and MNGA does it faster and cleaner and the resulting MagneGas burns more the 3X hotter than any of it's possible competitors. Competition is not that deep - acetylene and propane are the majors and there are inherent problems with both from volatility with acetylene and wide burn area with Propane.
8: Flame temp. was discussed and it should be considered a fact that MagneGas burns at temps pushing 12000 to 15000 degress - period end of story. They are working on perfecting a new verison of the gas that will consistently burn at 15000 degrees, it is derived from oil based feedstocks. This was the most impressive part of the day for me. It was a very enlightening discussion.
9: IP and possible Patent Infringement - MNGA is not infringing on anyone else's patents. There process is different than other processes intended for "Liquid Gasification" process, in addition to the desired end result being only Magnegas.
So that answers the questions posted.
The following message details yesterday's MangeGas presentation. It was posted to the MagneGas message board on YahooFinance. The account name that posted it is "unclegianni".
The demo day was very informative and quite fun...it is always good to put a face to a name and the folks I met yesterday at the event were genuine and provided very good information.
There were questions posted that I would like to answer, so here we go:
1: The gas that is produced from "sewage" based feedstock is not as potent as the gas produced from "oil" based feedstock. It will not have the same characteristics as the gas that is being positioned for the co-combustion plans.
2: MNGA has experience processing sewage in Italy, they have been doing it there for a long time. The sterilization process is faster and eliminates all pathogens - so the water and other by-products (clean "sludge") can be used for irrigation, put back into the environment cleanly and be used in the other application like fertilizer.
3: The European, and other distributors, are independent companies, MNGA does not maintain any ownership in them.
4: A lot of time was spent on the slow adoption of MNGA versus Acetylene. The long and short of it are that they are breaking into a market that has not changed in 40 plus years and that quite simply takes time, consistency and effort. There are lots of road blocks but the team at MNGA has opted to take a top down approach and work with the trade unions and Fire Departments to educate them on the benefits and have them endorse and use the product to that others will see instant validation. Think of the process that someone would have to go thru in NYC in order to use a new gas, it does not happen unless the Fire Department is on board, plain and simple. Start at the top and will flow down. There was a continuous theme about the level of success in the demonstrations and presentations to everyone from pipe cutters and emergency service all the way up to former GE scientists that feel once the market accepts the facts and adopts the change that this valuation could be well into the billions.
5. They company has ZERO debt, they are self funding at this point. Sales are fairly steady and on the rise and they did not express an immediate need to bring in capital.
6. The Co-Combustion process was discussed in detail - what they told us was practically unbelievable. MagneGas will be used in the "cleaning" process at coal plants. It will be introduced to the smoke and particulate matter that comes out of a "smoke stack" and applied to burn the particulate and reduce smoke emissions to "zero". The additional heat that is created can be re-introduced into the steam creation process kind of like a turbo charge or after burn and enhance the overall output for the facility while at the same time practically eliminating emission issues.
7. Syngas VS Magnegas - the process is different in creating the gas and MNGA does it faster and cleaner and the resulting MagneGas burns more the 3X hotter than any of it's possible competitors. Competition is not that deep - acetylene and propane are the majors and there are inherent problems with both from volatility with acetylene and wide burn area with Propane.
8: Flame temp. was discussed and it should be considered a fact that MagneGas burns at temps pushing 12000 to 15000 degress - period end of story. They are working on perfecting a new verison of the gas that will consistently burn at 15000 degrees, it is derived from oil based feedstocks. This was the most impressive part of the day for me. It was a very enlightening discussion.
9: IP and possible Patent Infringement - MNGA is not infringing on anyone else's patents. There process is different than other processes intended for "Liquid Gasification" process, in addition to the desired end result being only Magnegas.
So that answers the questions posted.
MagneGas Expands Geographic Footprint With New Distributor
MagneGas and Welder Services Inc. Partner to distribute MagneGas throughout the state of Indiana
TAMPA, Fla., Jan. 14, 2014 /PRNewswire/ -- MagneGas Corporation ("MagneGas" or the "Company") (NASDAQ: MNGA), the developer of a technology that converts liquid waste into hydrogen-based fuels, announced today that Welder Services Inc. or (WSI) of Fort Wayne Indiana has signed on to distribute MagneGas™ fuel throughout the state.
"Partnering with WSI allows MagneGas to focus its reach on a state with heavy industry that is a great fit for MagneGas fuel," stated Terry Vernille, Vice President of Sales for MagneGas. "WSI has the reach and customer base we are looking for to properly introduce our alternative fuel to the market in Indiana."
"Partnering with MagneGas will give us the added benefits to compete with larger companies who do not have access to this fuel," stated Dan Pontius, GM of Welding Services Inc. "We are always trying to improve as a company by providing our customers with the most up to date technology on the market."
The MagneGas IR App is now available for free in Apple's App Store for the iPhone or iPad http://bit.ly/AfLYww and at Google Play http://bit.ly/Km2iyk for Android mobile devices.
To be added to the MagneGas investor email list, please email pcarlson@kcsa.com with MNGA in the subject line.
About Welding Services Inc.
Welders Services, Inc. was founded in 1975 by its current President, Daniel Mulhern, with major emphasis at that time on the sale and repair of welding equipment and supplies. Welder Services, Inc. continued growing into a major player in the industrial and medical gas spectrum in the Fort Wayne and surrounding area. Its actions in the past have led it to become one of the largest, most complete independent welding distributors in Indiana. http://www.welderservices.com/
About MagneGas Corporation
Founded in 2007, Tampa-based MagneGas Corporation (NASDAQ: MNGA) is the producer of MagneGas™, a natural gas alternative and metal working fuel that can be made from certain industrial, municipal, agricultural and military liquid wastes following the receipt of appropriate governmental permits.
The Company's patented Plasma Arc Flow™ process gasifies liquid waste, creating a clean burning hydrogen based fuel that is essentially interchangeable with natural gas. MagneGas can be used for metal working, cooking, heating, powering bi-fuel automobiles and more. For more information on MagneGas, please visit the Company's website at www.magnegas.com.
FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The Company is currently using new ethylene glycol to produce fuel until proper permits to process used liquid waste have been obtained.
For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov.
SOURCE MagneGas Corporation
Released January 14, 2014
Below is the Barchart Opinion on MNGA
Short Term Indicators Average: 80% Buy
Medium Term Indicators Average: 75% Buy
Long Term Term Indicators Average: 33% Buy
Overall Term Indicators Average: 72% Buy
Here is the link to the site:
http://www.barchart.com/opinions/stocks/MNGA
Any thoughts on the recent rise? or the future of the company?
Tauriga Sciences Appoints ProActive Capital Group as Capital Markets & Digital Media Advisor
Tauriga Sciences, Inc. (OTCQB:TAUG), a diversified life sciences company focused on proprietary biotherapeutics and diagnostics, novel medical devices and consumer healthcare businesses, has today announced the appointment of ProActive Capital Group as its new Capital Markets Advisory and Digital Media Strategies firm. Tauriga will utilize ProActive Capital's well-established relationships with the investment communities to assist the company in fostering productive relationships with analysts, brokers, potential investors, and other financial professionals, as well as to manage its unique digital media program.
"As we continue to implement our growth strategy, we are very pleased to have retained the services of ProActive Capital Group, a leading life sciences advisory firm," Tauriga's CEO Seth M. Shaw stated. "ProActive Capital has an outstanding track record in helping to convey the value of biotech companies to the investment and media communities. We believe the timing is right to articulate our investment thesis to expand our reach and increase our visibility with key stakeholders. We look forward to embarking on a significant new and expanded strategy so that we can achieve a fair valuation that clearly reflects the intrinsic value of our scientific initiatives."
"We are delighted to have been selected by Tauriga Sciences, a leading company in the proprietary biotherapeutics and diagnostics market," stated Jeff Ramson, Founder and CEO of ProActive Capital Group. "We look forward to developing and implementing a quality capital markets and digital media strategy to increase Tauriga's visibility and build its brand among the key audience segments including the investment and media communities."
About Tauriga Sciences, Inc.
Tauriga Sciences, Inc. (TAUG) is a life sciences company that focuses on proprietary biotherapeutics and diagnostics, novel medical devices and consumer healthcare. The mission of the Company is to acquire and build a diversified portfolio of medical technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. The Company's new corporate website can be found at www.taurigasciences.com.
About ProActive Capital Group, LLC
ProActive Capital Group, LLC ("PCG") is dedicated to the discovery and creation of value, specifically in the emerging public company marketplace. PCG provides a unique service that combines capital market advisory services with traditional and social/digital media communications. The firm's overarching goal is to develop and maintain stakeholder awareness from all constituents in order to maximize shareholder value. PCG's capital market advisory services include key strategies to increase corporate transparency and credibility for companies across all sectors. The firm's communications services leverage traditional, digital and social media channels to further increase awareness through proprietary and best-of-breed media strategies. Communicating the client's story accurately and effectively to a wide but concentrated audience is tantamount to maximizing exposure to its current and potential shareholders. For more information: www.proactivecapital.com.
DISCLAIMER
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission.
This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
CONTACT:
For further information regarding
Tauriga Sciences, Inc.
Mr. Seth M. Shaw
Chairman & Chief Executive Officer
Tauriga Sciences, Inc.
www.taurigasciences.com
New York: +1-917-796-9926
Montreal: +1-514-840-3697
Email: sshaw@tauriga.com
Investor Contact:
Adam Holdsworth
ProActive Capital
(646) 862-4607
adamh@proactivecapital.com
Media Contact:
Sandra Lee
ProActive Capital
(646) 862-4608
slee@proactivecapital.com
TAUG has been upgraded from "OTC Pink Limited" status to "OTCQB" status.
Below is the press release...
Tier Change
Wed, Jul 03, 2013 12:00 - Tauriga Sciences, Inc. (TAUG: OTCQB) - Tier Change - The symbol, TAUG, no longer is classified as OTC Pink Limited. As of Wed, Jul 03, 2013, TAUG resides in the OTCQB tier. You may find a complete list of tier changes at otcmarkets.com.
Tauriga Sciences Inc. Fully Repays $150,000 Payment on Convertible Promissory Note
LOS ANGELES, Jun 28, 2013 (GLOBE NEWSWIRE via COMTEX) -- Tauriga Sciences, Inc. (TAUG), a diversified life sciences company focused on proprietary biotherapeutics and diagnostics, novel medical devices and consumer healthcare businesses, today announced it has successfully retired the $150,000 payment JMJ Financial made to the Company under the Promissory Note signed on October 19, 2012. The Company is working diligently to restore and create shareholder value through the current business activities and is confident in its ability to execute.
Commenting on the full repayment of the $150,000 payment under the Note, Tauriga Chief Executive Officer Seth M. Shaw stated, "We have an excellent working relationship with this institutional investor and are grateful for the financial support that we have received and expect to continue to receive from them. We are appreciative that JMJ Financial worked with us to satisfy this obligation, so that management can focus on the fundamentals which continue to improve."
About Tauriga Sciences, Inc.
Tauriga Sciences, Inc. (otcqb:TAUG) is a life sciences company that focuses on proprietary biotherapeutics and diagnostics, novel medical devices and consumer healthcare. The mission of the Company is to acquire and build a diversified portfolio of medical technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. The Company's new corporate website can be found at www.taurigasciences.com.
DISCLAIMER
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission.
This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
CONTACT: For further information regarding Tauriga Sciences, Inc.
Mr. Seth M. Shaw
Chairman & Chief Executive Officer
Tauriga Sciences, Inc.
www.taurigasciences.com
New York: +1-917-796-9926
Montreal: +1-514-840-3697
Email: sshaw@tauriga.com
Tauriga Sciences, Inc. to Commence Presentations to Key Distribution Groups in the Southeast United States for the Conversion to "100% Tree-Free" Biodegradable Products to the Hospitals They Supply
Mon, Jun 17, 2013 8:00 AM EDT
SAN FRANCISCO, June 17, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (TAUG), a diversified life sciences company focused on investing in proprietary biotherapeutics and diagnostics, novel medical devices and consumer healthcare, has today announced that the Company and Green Hygienics, Inc. ("Green Hygienics"), in the coming week, will commence presentations to key distribution groups in the southeast United States who have a mission for the conversion to environmentally friendly products for the hospitals that they supply. Tauriga has been making great strides since the execution of the Licensing Agreement ("Licensing Agreement") with Green Hygienics, a wholly-owned subsidiary of Green Innovations Ltd. (GNIN), for the North American exclusive distribution for commercial use of its 100% tree-free, bamboo-based, biodegradable, hospital grade wipes along with other complementary green products. The Company's long-term vision, pursuant to the license agreement, is the successful marketing of 100% tree-free, bamboo-based products including, but not limited to, wipes, bath tissue, paper towels, diapers, sanitary napkins and more, to the commercial marketplace of North America. All Green Hygienics' products are available through exclusive licensing agreements between Green Hygienics and its strategic partners and their respective manufacturing facilities in mainland China.
In addition, Tauriga is pleased to report to shareholders that the Company has now paid a total of $128,750 to Green Hygienics pursuant to the Licensing Agreement, therefore the Company has now received 321,875 shares of GNIN for that paid in capital. To completely satisfy the financial terms of the previously announced 5 year exclusive North American Licensing Agreement, the Company is required to pay a total of $250,000 to Green Hygienics on or before September 1, 2013, for which the Company receives 625,000 shares of GNIN restricted stock. Both companies and their respective management teams are working diligently to generate meaningful revenues during calendar year 2013.
Commenting on the Licensing Agreement progress, Tauriga CEO Seth M. Shaw expressed, "The Company is excited to start its presentations to the commercial marketplace and has great confidence in both the quality and social benefits of the Green Hygienics' product line. Our initial strategy will be to target U.S. and Canada based hospitals, adult and nursing homes, school districts, private medical practices, and the distribution companies that service these industries. It is of great importance to establish relationships with major distributors servicing large medical establishments and educate them as to the merits of our licensed product line. The Company expects to fully satisfy the financial terms of the Licensing Agreement in the near term and will notify shareholders when this important milestone is accomplished."
According to the American Hospital Association (AHA), as of 2011, there were 5,724 registered U.S. hospitals and, according to the U.S. Census Bureau Statistical Abstract of the United States: 2012, as of 2009, there were 15,700 nursing homes in the U.S. with approximately 1.4 million residents.
About Tauriga Sciences, Inc.
Tauriga Sciences, Inc. (TAUG) is a life sciences company that focuses on proprietary biotherapeutics and diagnostics, novel medical devices and consumer healthcare. The mission of the Company is to acquire and build a diversified portfolio of medical technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. The Company's new corporate website can be found at www.taurigasciences.com.
About Green Innovations Ltd.
Green Innovations Ltd. (GNIN), through its wholly-owned subsidiary Green Hygienics, Inc., is the exclusive licensed North American distributor of American Hygienics Corporation's 100% tree-free bamboo-based product line, including personal care and paper-based goods. The Company provides consumers the opportunity to enjoy high-quality and performance eco-friendly goods from dedicated experts that have been producing bamboo products for over a decade, along with the cost-benefit of local raw material manufacturing, and the satisfaction of knowing that by using these products they are doing their part to reduce their carbon footprint and to continue the movement towards a more healthy and sustainable planet. The Company's website can be found at www.greeninnovationsltd.com.
DISCLAIMER
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission.
This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
Contact:
For further information regarding Tauriga Sciences, Inc.
Mr. Seth M. Shaw
Chairman & Chief Executive Officer
Tauriga Sciences, Inc.
www.taurigasciences.com
New York: +1-917-796-9926
Montreal: +1-514-840-3697
Email: sshaw@tauriga.com
I wasn't implying that it was you, just letting everyone know about it. I have TD Ameritrade and the high for today is listed at $0.415. Also, in the trades section for TAUG on iHub the trade I mentioned is listed.
Go to the trades for today and you will find it. It was at 11:30am.
Someone just bought 100,000 shares at $0.415. That mistake with the decimal place just cost them $37,350!! Be careful placing orders -_- lol
Stella Sung also purchased shares. Check the Form 4's.
Actually $5.175 million, my bad. And yea it's a lot but the capital will likely help the company to secure deals and grow the business. It looks like a necessary step in order to expand.
It is a offering to Hanover Holdings for $5 million dollars worth of shares at $0.055 per share. This will give Tauriga up to $5 million dollars in instant capital to use on new deals.
The deal with Hanover Holdings was published on Tuesday, June 11. Go to the News section to view it.
$5 million worth of shares are being offered to Hanover Holdings at $0.055 per share. So far $175k worth of shares have been sold to Hanover Holdings as part of this offering.
This will provide Tauriga with the capital to embark in new deals and expand the company.
Back on the rise, recovering from the big dump. Close to 0.07.
Good news after good news. More deals being made each day. Instant funding deal just completed. IMO the stock price should continue to build support and grow. Seth has definitely turned this company around and the future has a great outlook.
Great news. This gives Tauriga instant funding for these new deals and many more!! Keep up the good news!!
Tauriga Sciences Inc. Completes $5 Million Stock Purchase Agreement With New York Based Institutional Investor Magna Group Through Flagship Equity Enhancement Program
GlobeNewswire - 48 mins ago
NEW YORK, June 5, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (TAUG), a diversified life sciences company focused on investing in proprietary biotherapeutics and diagnostics, novel medical devices and consumer healthcare, is pleased to announce that the Company has entered into a common stock purchase agreement for a $5 million Equity Enhancement Program with a Magna Group affiliate fund, Hanover Holdings I, LLC (the "Investor"), headquartered in New York, NY. The program will enable Tauriga Sciences to capitalize on important business opportunities that will increase shareholder value.
The Equity Enhancement Program, a Magna Group proprietary product, allows, but does not obligate, the Company to issue and sell up to $5 million of shares of common stock to the Investor as needed over the 36-month period following the effectiveness of a registration statement the Company has agreed to file with the Securities and Exchange Commission by no later than June 24, 2013 to register the resale of the stock by the Investor.
Tauriga's CEO Mr. Seth M. Shaw stated, "The execution of this stock purchase agreement is a major milestone for the Company as it establishes an important financial safety net at terms highly beneficial to the shareholders. The Company will coordinate closely with its institutional investors if and when management decides to secure capital through this instrument. The Company deeply appreciates the confidence that Magna Group has demonstrated in its business model and future prospects."
"We are pleased to build off of our initial Convertible Note investment with Tauriga Sciences," stated Joshua Sason, the Chief Executive Officer of Magna Group. "To this point, we have enjoyed working with the Company and are excited to build on our relationship through our Equity Enhancement Program. We feel that this structure is an excellent resource for Tauriga as they look to continue to increase value by expanding the Company's healthcare portfolio."
No problem. Great news for both companies!!
The deal was executed on May 31st so I'm guessing we got the shares at the price for that day which was around $0.35. It's up to $0.47 today (34% overall increase for us already)!!
Tauriga Sciences Inc. Signs Exclusive North American License Agreement With Green Innovations Inc. for Commercialization of Bamboo-Based "Tree-Free" Products Including Hospital Grade Biodegradable Disinfectant Wipes
GlobeNewswire
SAN FRANCISCO, June 4, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (TAUG), a life sciences company creating a diversified portfolio of medical technology assets, novel medical devices and consumer healthcare, is pleased to announce the execution of an exclusive license agreement ("License Agreement") with Green Hygienics, Inc., a wholly-owned subsidiary of Green Innovations Ltd. (GNIN), to market bamboo-based 100% tree-free medical products to the North American commercial marketplace. This License Agreement was executed May 31, 2013 and is valid for a duration of 5 years. Under the terms of the License Agreement, Tauriga will realize the potential revenues generated from sales in North America, however the net profits will be split equally (50% each) between the two companies. Additionally, Tauriga shall receive an equity stake in Green Innovations amounting to 625,000 shares of restricted common stock, in consideration for both the paid in capital and joint marketing efforts. Complete terms and conditions of this License Agreement will be disclosed in a Form 8-K to be filed by the Company in the next few days.
The Company anticipates that the initial revenues (pursuant to this License Agreement) will be generated during calendar year 2013; however at this point in time, it is premature to establish any type of revenue or earnings guidance. The initial $65,000 payment from Tauriga (due at signing) has been paid to Green Innovations, so the Company has already acquired 162,500 shares of GNIN and fully expects to acquire the entirety of the 625,000 shares pursuant to the license agreement.
Tauriga's CEO, Seth M. Shaw, stated, "By entering into this License Agreement, the Company has positioned itself to generate revenues through the marketing of a high quality product line with substantial social benefits. After extensive due diligence, management is confident in Green Hygienics' manufacturing infrastructure as well as the potential market acceptance of such products in the marketplace of the North American continent. We are also pleased to become shareholders of Green Innovations, through this agreement, because it bolsters our balance sheet and we believe strongly in the business prospects of their company and management team."
According to the American Hospital Association (AHA), as of 2011, there were 5,724 registered U.S. hospitals and, according to the U.S. Census Bureau Statistical Abstract of the United States: 2012, as of 2009, there were 15,700 nursing homes in the U.S. with approximately 1.4 million residents.
Tauriga Sciences Inc. Signs Exclusive North American License Agreement With Green Innovations Inc. for Commercialization of Bamboo-Based "Tree-Free" Products Including Hospital Grade Biodegradable Disinfectant Wipes
GlobeNewswire
SAN FRANCISCO, June 4, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (TAUG), a life sciences company creating a diversified portfolio of medical technology assets, novel medical devices and consumer healthcare, is pleased to announce the execution of an exclusive license agreement ("License Agreement") with Green Hygienics, Inc., a wholly-owned subsidiary of Green Innovations Ltd. (GNIN), to market bamboo-based 100% tree-free medical products to the North American commercial marketplace. This License Agreement was executed May 31, 2013 and is valid for a duration of 5 years. Under the terms of the License Agreement, Tauriga will realize the potential revenues generated from sales in North America, however the net profits will be split equally (50% each) between the two companies. Additionally, Tauriga shall receive an equity stake in Green Innovations amounting to 625,000 shares of restricted common stock, in consideration for both the paid in capital and joint marketing efforts. Complete terms and conditions of this License Agreement will be disclosed in a Form 8-K to be filed by the Company in the next few days.
The Company anticipates that the initial revenues (pursuant to this License Agreement) will be generated during calendar year 2013; however at this point in time, it is premature to establish any type of revenue or earnings guidance. The initial $65,000 payment from Tauriga (due at signing) has been paid to Green Innovations, so the Company has already acquired 162,500 shares of GNIN and fully expects to acquire the entirety of the 625,000 shares pursuant to the license agreement.
Tauriga's CEO, Seth M. Shaw, stated, "By entering into this License Agreement, the Company has positioned itself to generate revenues through the marketing of a high quality product line with substantial social benefits. After extensive due diligence, management is confident in Green Hygienics' manufacturing infrastructure as well as the potential market acceptance of such products in the marketplace of the North American continent. We are also pleased to become shareholders of Green Innovations, through this agreement, because it bolsters our balance sheet and we believe strongly in the business prospects of their company and management team."
According to the American Hospital Association (AHA), as of 2011, there were 5,724 registered U.S. hospitals and, according to the U.S. Census Bureau Statistical Abstract of the United States: 2012, as of 2009, there were 15,700 nursing homes in the U.S. with approximately 1.4 million residents.
Exactly, TAUG bought the licensing rights for North America.
ITL is not the only thing this company is focused on. Tauriga is no longer involved with ITL. Tauriga is a 9% stock holder, nothing more. Tauriga is now correctly focusing on other possible ways to enhance the company. The recent deal completed with Green Innovations is the start of hopefully many different acquisitions in the future that can greatly benefit this company. Seth is taking this company in the right direction and the future will prove that.
Incorrect, the deal was finalized on May 31st and announced earlier today.
So true Crazyhorses. It's unfortunate how much of an effect bashers can have on a stock.
To All Investors - Do not always believe what you read on the Internet and message boards. Do your own DD and find out for your own about a stock before buying or selling.
Exactly, need to build a support level. High volume and close around .07-.075 would be great progress for today.
Don't want too big of a jump right away, slow and steady wins the race.
Green Innovations and Tauriga Sciences, Inc. execute Exclusive North American Licensing Agreement for the Commercialization of Hospital Grade Products including 100% Tree-Free Bamboo-Based Disinfectant Wipes
CAPE CORAL, Fla., June 3, 2013 /PRNewswire/ -- Green Innovations Ltd. (OTCQB: GNIN) (OTCBB: GNIN) ("Green Innovations" or the "Company") is pleased to announce that on May 31, 2013, its wholly-owned subsidiary, Green Hygienics, Inc. ("Green Hygienics"), executed an exclusive North American licensing agreement with Tauriga Sciences Inc. (OTCQB: TAUG) ("Tauriga") (the "Licensing Agreement") for the commercial launch of hospital grade products including 100% tree-free bamboo-based biodegradable disinfectant wipes.
"With the completion of this strategic relationship with Tauriga Sciences, we have taken an important step in joining forces with an expanded sales force to reach commercial entities for an exclusive line of our products," stated Philip Rundle, CEO of Green Innovations. "Tauriga Sciences has an established network in place reach to hospitals, nursing homes, schools, and other potential commercial/institutional purchasers of our products across the country. We look forward to working together with them to reach new customers in new markets for the benefit of both companies."
According to the American Hospital Association (AHA), as of 2011, there were 5,724 registered U.S. hospitals and, according to the U.S. Census Bureau Statistical Abstract of the United States: 2012, as of 2009, there were 15,700 nursing homes in the U.S. with approximately 1.4 million residents.
Tauriga's CEO, Seth M. Shaw, expressed, "The exclusive North American licensing agreement with Green Hygienics provides Tauriga with an important potential revenue stream in the short, intermediate, and long terms. According to industry research, the annual market for disinfectant wipes by hospitals, nursing homes, and other health care facilities is quite large. Considering the overall market size, the potential sales to be achieved by the Green Hygienics and Tauriga Sciences partnership would represent a significant boost in revenues and shareholder value."
The terms of the Licensing Agreement provide for an equal share of the profits between the two companies following an initial $65,000 cash payment to Green Hygienics from Tauriga (due at signing) which has already been received by the Company.
The companies currently anticipate having the first hospital grade products available for sale to wholesalers, retailers, and for direct purchase during Fall 2013.
Green Innovations and Tauriga Sciences, Inc. execute Exclusive North American Licensing Agreement for the Commercialization of Hospital Grade Products including 100% Tree-Free Bamboo-Based Disinfectant Wipes
CAPE CORAL, Fla., June 3, 2013 /PRNewswire/ -- Green Innovations Ltd. (OTCQB: GNIN) (OTCBB: GNIN) ("Green Innovations" or the "Company") is pleased to announce that on May 31, 2013, its wholly-owned subsidiary, Green Hygienics, Inc. ("Green Hygienics"), executed an exclusive North American licensing agreement with Tauriga Sciences Inc. (OTCQB: TAUG) ("Tauriga") (the "Licensing Agreement") for the commercial launch of hospital grade products including 100% tree-free bamboo-based biodegradable disinfectant wipes.
"With the completion of this strategic relationship with Tauriga Sciences, we have taken an important step in joining forces with an expanded sales force to reach commercial entities for an exclusive line of our products," stated Philip Rundle, CEO of Green Innovations. "Tauriga Sciences has an established network in place reach to hospitals, nursing homes, schools, and other potential commercial/institutional purchasers of our products across the country. We look forward to working together with them to reach new customers in new markets for the benefit of both companies."
According to the American Hospital Association (AHA), as of 2011, there were 5,724 registered U.S. hospitals and, according to the U.S. Census Bureau Statistical Abstract of the United States: 2012, as of 2009, there were 15,700 nursing homes in the U.S. with approximately 1.4 million residents.
Tauriga's CEO, Seth M. Shaw, expressed, "The exclusive North American licensing agreement with Green Hygienics provides Tauriga with an important potential revenue stream in the short, intermediate, and long terms. According to industry research, the annual market for disinfectant wipes by hospitals, nursing homes, and other health care facilities is quite large. Considering the overall market size, the potential sales to be achieved by the Green Hygienics and Tauriga Sciences partnership would represent a significant boost in revenues and shareholder value."
The terms of the Licensing Agreement provide for an equal share of the profits between the two companies following an initial $65,000 cash payment to Green Hygienics from Tauriga (due at signing) which has already been received by the Company.
The companies currently anticipate having the first hospital grade products available for sale to wholesalers, retailers, and for direct purchase during Fall 2013.
Summary of recent stock purchases:
Seth Shaw (CEO) - 10,253,800 shares
May 30: 100,000 at .06
May 15: 100,000 at .07
May 13: 35,000 at .07
May 7: 200,000 at .08
March 8: 145,300 at .065
Stella Sung (COO) - 5,275,000 shares
May 24: 25,000 at .06
May 23: 25,000 at .06
May 15: 125,000 at .08
On May 24, 2013, GenVec’s Board of Directors approved a Plan of Complete Liquidation and Dissolution of the Company (the “Plan of Dissolution”), subject to stockholder approval. The Company’s Board of Directors has concluded, after extensive and careful consideration of the Company's strategic alternatives and the terms and conditions of the Plan of Dissolution, that the liquidation and dissolution of the Company, pursuant to the Plan of Dissolution, is in the best interests of the Company and its stockholders.
If you think Tauriga is so terrible, then sell your shares and invest in ITL and f*** off. All of your constant rambling is pointless.
I think you guys forgot that Tauriga now has NO control over ITL. Whatever happens with them, happens. No use in talking about it.
It is time for Tauriga to focus on new deals for this company. Seth is working on this as he has shown recently. Have some faith and stop trash talking about nothing.
Seth bought 200,000 shares at $0.08. He now owns 8,553,800.
If you dislike the company, then just move on. Nobody wants to hear your crazy rants.